INTERNATIONAL PATENT: ONTRACK THERAPEUTICS LIMITED FILES APPLICATION FOR "4-(6-OXO-2-(TRIFLUOROMETHYL)-3,6-DIHYDROCHROMENO[7,8-D]IMIDAZOL-8-YL)BENZONITRILE FOR USE IN THE TREATMENT OF POSITIVE SYMPTOMS IN SCHIZOPHRENIA"

GENEVA, June 2 -- ONTRACK THERAPEUTICS LIMITED (1st FloorOne Suffolk Way, SevenoaksKent TN13 1YL) filed a patent application (PCT/GB2024/052961) for "4-(6-OXO-2-(TRIFLUOROMETHYL)-3,6-DIHYDROCHROMENO[7,8-D]IMIDAZOL-8-YL)BENZONITRILE FOR USE IN THE TREATMENT OF POSITIVE SYMPTOMS IN SCHIZOPHRENIA" on Nov 22, 2024. With publication no. WO/2025/109339, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PFEIFFER, Thomas (44 Cardinals WayLondon Greater London N19 3UZ), HO, Man-Ling (Apartment 12-55 Gasholders Building1 Lewis Cubitt...